Jay Albany
Jay Albany, CFA, has more than a decade's experience conducting equity research and analysis in life sciences and other high tech industries. He is a senior analyst at SeeThruEquity LLC, after a stint as senior vice president of equity research. Previously, Albany served as senior vice president of capital markets at Emissary Capital LLC, after working as a research analyst at Skellig Capital LLC and as a security analyst at Calisto Capital Management Inc. He began his financial services career at kozmo.com as manager of business development. Albany is a member of the New York Society of Securities Analysts and is a CFA charterholder. He earned a bachelor of arts degree from Columbia University.
Recent Quotes
"INNV has been developing a promising growth engine in what appears to be a replicable process of identifying promising OTC products that target large markets—and then leveraging its Beyond Human sales platform."
—
Jay Albany, SeeThruEquity
(8/9/17)
more >
"We find RESX to be a worthwhile investment."
—
The Life Sciences Report Interview with Jay Albany
(10/28/15)
more >
"CYP's lead medical technology platform has very exciting potential."
—
The Life Sciences Report Interview with Jay Albany
(10/28/15)
more >
"We've seen a lot of acceleration for AEMD since the Hemopurifier was used successfully to treat an Ebola patient in Germany."
—
The Life Sciences Report Interview with Jay Albany
(10/28/15)
more >
